280 related articles for article (PubMed ID: 24731928)
21. Performance of the Applied Biosystems HIV-1 Genotyping Kit with Integrase.
Moore HP; Palumbo PJ; Notarte KI; Fogel JM; Cummings V; Gamble T; Del Rio C; Batey DS; Mayer KH; Farley JE; Remien RH; Beyrer C; Hudelson SE; Eshleman SH;
J Clin Microbiol; 2024 Jun; 62(6):e0013624. PubMed ID: 38727213
[TBL] [Abstract][Full Text] [Related]
22. Analysis of transmitted HIV-1 drug resistance using 454 ultra-deep-sequencing and the DeepChek(®)-HIV system.
Garcia-Diaz A; McCormick A; Booth C; Gonzalez D; Sayada C; Haque T; Johnson M; Webster D
J Int AIDS Soc; 2014; 17(4 Suppl 3):19752. PubMed ID: 25397497
[TBL] [Abstract][Full Text] [Related]
23. HIV-1 genotyping of the protease-reverse transcriptase and integrase genes to detect mutations that confer antiretroviral resistance.
Van den Eede P; Van Wesenbeeck L; Verlinden Y; Feyaerts M; Smits V; Verheyen A; Vanhooren L; Deloof A; Villacian J; Pattery T
Methods Mol Biol; 2013; 1030():37-55. PubMed ID: 23821259
[TBL] [Abstract][Full Text] [Related]
24. Reliability and clinical relevance of the HIV-1 drug resistance test in patients with low viremia levels.
Santoro MM; Fabeni L; Armenia D; Alteri C; Di Pinto D; Forbici F; Bertoli A; Di Carlo D; Gori C; Carta S; Fedele V; D'Arrigo R; Berno G; Ammassari A; Pinnetti C; Nicastri E; Latini A; Tommasi C; Boumis E; Petrosillo N; D'Offizi G; Andreoni M; Ceccherini-Silberstein F; Antinori A; Perno CF
Clin Infect Dis; 2014 Apr; 58(8):1156-64. PubMed ID: 24429430
[TBL] [Abstract][Full Text] [Related]
25. Performance of Celera RUO integrase resistance assay across multiple HIV-1 subtypes.
Wallis CL; Viana RV; Saravanan S; Silva de Jesus C; Zeh C; Halvas EK; Mellors JW
J Virol Methods; 2017 Mar; 241():41-45. PubMed ID: 27993614
[TBL] [Abstract][Full Text] [Related]
26. Deep sequencing does not reveal additional transmitted mutations in patients diagnosed with HIV-1 variants with single nucleoside reverse transcriptase inhibitor resistance mutations.
Pingen M; van der Ende ME; Wensing AM; el Barzouhi A; Simen BB; Schutten M; Boucher CA
HIV Med; 2013 Mar; 14(3):176-81. PubMed ID: 22989004
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of an affordable HIV-1 virological failure assay and antiretroviral drug resistance genotyping protocol.
Bronze M; Aitken SC; Wallis CL; Steegen K; Stuyver LJ; de Wit TF; Stevens W
J Virol Methods; 2013 Dec; 194(1-2):300-7. PubMed ID: 23994150
[TBL] [Abstract][Full Text] [Related]
28. Performance evaluation of the Vela Dx Sentosa next-generation sequencing system for HIV-1 DNA genotypic resistance.
Raymond S; Nicot F; Abravanel F; Minier L; Carcenac R; Lefebvre C; Harter A; Martin-Blondel G; Delobel P; Izopet J
J Clin Virol; 2020 Jan; 122():104229. PubMed ID: 31809945
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of Vela Diagnostics HIV-1 genotyping assay on an automated next generation sequencing platform.
May S; Adamska E; Tang J
J Clin Virol; 2020 Jun; 127():104376. PubMed ID: 32344322
[TBL] [Abstract][Full Text] [Related]
30. An Efficient Microarray-Based Genotyping Platform for the Identification of Drug-Resistance Mutations in Majority and Minority Subpopulations of HIV-1 Quasispecies.
Martín V; Perales C; Fernández-Algar M; Dos Santos HG; Garrido P; Pernas M; Parro V; Moreno M; García-Pérez J; Alcamí J; Torán JL; Abia D; Domingo E; Briones C
PLoS One; 2016; 11(12):e0166902. PubMed ID: 27959928
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of GS Junior and MiSeq next-generation sequencing technologies as an alternative to Trugene population sequencing in the clinical HIV laboratory.
Ram D; Leshkowitz D; Gonzalez D; Forer R; Levy I; Chowers M; Lorber M; Hindiyeh M; Mendelson E; Mor O
J Virol Methods; 2015 Feb; 212():12-6. PubMed ID: 25445792
[TBL] [Abstract][Full Text] [Related]
32. Development and evaluation of an assay for HIV-1 protease and reverse transcriptase drug resistance genotyping of all major group-M subtypes.
Aitken SC; Kliphuis A; Wallis CL; Chu ML; Fillekes Q; Barth R; Stevens W; Rinke de Wit TF; Schuurman R
J Clin Virol; 2012 May; 54(1):21-5. PubMed ID: 22306272
[TBL] [Abstract][Full Text] [Related]
33. Automated sequence analysis and editing software for HIV drug resistance testing.
Struck D; Wallis CL; Denisov G; Lambert C; Servais JY; Viana RV; Letsoalo E; Bronze M; Aitken SC; Schuurman R; Stevens W; Schmit JC; Rinke de Wit T; Perez Bercoff D
J Clin Virol; 2012 May; 54(1):30-5. PubMed ID: 22425336
[TBL] [Abstract][Full Text] [Related]
34. Ultra-deep sequencing improves the detection of drug resistance in cellular DNA from HIV-infected patients on ART with suppressed viraemia.
Rodriguez C; Nere ML; Demontant V; Charreau I; Mercier-Darty M; Delagreverie H; Salmona M; de Castro N; Chaix ML; Molina JM; Delaugerre C
J Antimicrob Chemother; 2018 Nov; 73(11):3122-3128. PubMed ID: 30137335
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of an in-house genotyping resistance test for HIV-1 drug resistance interpretation and genotyping.
Chen JH; Wong KH; Chan K; Lam HY; Lee SS; Li P; Lee MP; Tsang DN; Zheng BJ; Yuen KY; Yam WC
J Clin Virol; 2007 Jun; 39(2):125-31. PubMed ID: 17449318
[TBL] [Abstract][Full Text] [Related]
36. Validation of an oligonucleotide ligation assay for quantification of human immunodeficiency virus type 1 drug-resistant mutants by use of massively parallel sequencing.
Beck IA; Deng W; Payant R; Hall R; Bumgarner RE; Mullins JI; Frenkel LM
J Clin Microbiol; 2014 Jul; 52(7):2320-7. PubMed ID: 24740080
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of a benchtop HIV ultradeep pyrosequencing drug resistance assay in the clinical laboratory.
Avidor B; Girshengorn S; Matus N; Talio H; Achsanov S; Zeldis I; Fratty IS; Katchman E; Brosh-Nissimov T; Hassin D; Alon D; Bentwich Z; Yust I; Amit S; Forer R; Vulih Shultsman I; Turner D
J Clin Microbiol; 2013 Mar; 51(3):880-6. PubMed ID: 23284027
[TBL] [Abstract][Full Text] [Related]
38. Primer ID Informs Next-Generation Sequencing Platforms and Reveals Preexisting Drug Resistance Mutations in the HIV-1 Reverse Transcriptase Coding Domain.
Keys JR; Zhou S; Anderson JA; Eron JJ; Rackoff LA; Jabara C; Swanstrom R
AIDS Res Hum Retroviruses; 2015 Jun; 31(6):658-68. PubMed ID: 25748056
[TBL] [Abstract][Full Text] [Related]
39. Development of a cost-effective assay for genotyping of HIV-1 non-B subtype for drug resistance.
Ammaranond P; Sanguansittianant S; Raju PA; Cunningham P; Horthongkham N
J Virol Methods; 2014 Apr; 199():102-7. PubMed ID: 24462843
[TBL] [Abstract][Full Text] [Related]
40. Next-generation sequencing of dried blood spot specimens: a novel approach to HIV drug-resistance surveillance.
Ji H; Li Y; Graham M; Liang BB; Pilon R; Tyson S; Peters G; Tyler S; Merks H; Bertagnolio S; Soto-Ramirez L; Sandstrom P; Brooks J
Antivir Ther; 2011; 16(6):871-8. PubMed ID: 21900719
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
